AMEDEI, AMEDEO
 Distribuzione geografica
Continente #
NA - Nord America 8.021
EU - Europa 6.450
AS - Asia 1.322
AF - Africa 18
OC - Oceania 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.825
Nazione #
US - Stati Uniti d'America 7.989
PL - Polonia 3.093
IT - Italia 989
IE - Irlanda 922
SE - Svezia 656
HK - Hong Kong 651
CN - Cina 231
UA - Ucraina 159
DE - Germania 136
FI - Finlandia 131
SG - Singapore 126
GB - Regno Unito 125
JO - Giordania 124
RU - Federazione Russa 106
VN - Vietnam 94
IN - India 42
FR - Francia 28
CA - Canada 27
TR - Turchia 27
CH - Svizzera 25
BE - Belgio 19
NL - Olanda 15
ES - Italia 14
AT - Austria 13
KR - Corea 10
AU - Australia 7
SC - Seychelles 7
CZ - Repubblica Ceca 6
JP - Giappone 6
MX - Messico 5
UG - Uganda 5
EG - Egitto 4
RO - Romania 4
EU - Europa 3
IL - Israele 3
BG - Bulgaria 2
BR - Brasile 2
GR - Grecia 2
IR - Iran 2
LV - Lettonia 2
NP - Nepal 2
AR - Argentina 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 15.825
Città #
Warsaw 3.090
Fairfield 1.305
Dublin 913
Chandler 707
Ashburn 662
Woodbridge 568
Seattle 553
Cambridge 522
Houston 506
Wilmington 413
Altamura 316
Lawrence 311
Jacksonville 253
Hong Kong 250
Ann Arbor 243
Princeton 226
Florence 201
Boston 137
Beijing 113
Boardman 96
New York 90
Dong Ket 86
Moscow 86
Medford 83
Singapore 83
San Diego 81
Shanghai 67
Buffalo 43
Milan 39
Pune 37
Falls Church 36
Kent 35
Hillsboro 31
London 31
Rome 29
West Jordan 28
Bern 22
Norwalk 21
Phoenix 21
Brussels 19
Redwood City 19
Toronto 19
Fiesole 18
Los Angeles 18
Izmir 17
Andover 16
Salerno 15
Dearborn 13
Vienna 13
Auburn Hills 12
Lappeenranta 11
Barcelona 10
Castelliri 10
Central 9
Nanjing 9
Frankfurt Am Main 8
Seoul 8
Kilburn 7
Munich 7
Sesto Fiorentino 7
Washington 7
Bologna 6
Chiswick 6
Guangzhou 6
Hounslow 6
Paris 6
Pisa 6
Bagno a Ripoli 5
Brno 5
Cesena 5
Frankfurt am Main 5
Kampala 5
Palermo 5
Verona 5
Amandola 4
Bremen 4
Cairo 4
Catania 4
Genoa 4
Menlo Park 4
Ottawa 4
Timonium 4
Arezzo 3
Buccinasco 3
Camerino 3
Chicago 3
Cuauhtémoc 3
Hangzhou 3
Helsinki 3
Laurel 3
Massa 3
Old Bridge 3
Perugia 3
Prescot 3
San Francisco 3
San Giovanni Valdarno 3
Scarperia e San Piero 3
Siena 3
Takasago 3
Tappahannock 3
Totale 12.763
Nome #
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 281
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 253
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 245
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 235
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 227
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 225
Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration 222
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 221
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 207
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 201
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 195
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 193
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 189
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 187
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 186
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 177
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 162
Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine 159
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 134
T cells in gastric cancer: friends or foes. 131
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 130
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 129
Gastric cancer and the epoch of immunotherapy approaches 128
The controversial role of Enterococcus faecalis in colorectal cancer 125
Thrombosis in vasculitis: from pathogenesis to treatment 123
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 123
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 122
I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine 119
Evaluation and comparison of short chain fatty acids composition in gut diseases 119
Healthy axis: Towards an integrated view of the gut-brain health 118
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy 118
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 116
Editorial of special issue “the interplay of microbiome and immune response in health and diseases” 115
Gut inflammatory diseases, infection, and nutrition 107
The lung microbiome: clinical and therapeutic implications 105
Effect of probiotics on oral candidiasis: A systematic review and meta-analysis 104
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 99
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 97
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 97
Designing a broad-spectrum integrative approach for cancer prevention and treatment 94
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 93
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 92
Targeting IL-23 in human diseases. 91
Usefulness of 13C-Urea Breath Test in the diagnosis of gastric Helicobacter pylori infection. 91
Role of diet and gut microbiota on Colorectal cancer immunomodulation 91
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 90
Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes 90
Broad targeting of resistance to apoptosis in cancer 89
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 89
Hydrogen sulfide effects on the survival of lactobacilli with emphasis on the development of inflammatory bowel diseases 89
In vivo relevance of CD30 in atopic dermatitis. 88
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 87
Circulating metabolites originating from gut microbiota control endothelial cell function 87
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori Neutrophil Activating Protein 86
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 86
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 86
Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma 85
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 85
The story so far: Helicobacter pylori and gastric autoimmunity. 84
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 84
Novel immunotherapeutic strategies of gastric cancer treatment 83
Cancer Immunotherapy: The Share of Cytokines and Chemokines 81
Helicobacter pylori and gastric autoimmunity. 80
New frontiers in cell-based immunotherapy of cancer. 80
The interplay between the microbiome and the adaptive immune response in cancer development 80
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 80
Exploring the food-gut axis in immunotherapy response of cancer patients 79
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 79
Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects 78
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds 78
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 77
Gastric autoimmunity: The role of Helicobacter pylori and molecular mimicry 76
Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma 76
Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma 75
Impact of acidosis on ζ-crystallin-mediated bcl-2 expression in leukemic cell lines 74
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 74
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects. 74
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 74
Effectiveness of a Khorasan Wheat–Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia 74
Gut microbiota and artificial intelligence approaches: A scoping review 74
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 74
Molecular specificity and functional properties of autoreactive T-cell response in human gastric autoimmunity. 73
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 73
In vitro expression of proalfa1 (I)collagen mRNA by human preosteoclastic cells 73
Skin CD30+ T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease 72
Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies 72
Broad targeting of angiogenesis for cancer prevention and therapy 72
Cancer prevention and therapy through the modulation of the tumor microenvironment 72
Role of immune response in yersinia pestis infection. 70
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 70
TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells. 70
Helicobacter pylori, asthma and allergy. 70
What is recent in pancreatic cancer immunotherapy? 69
Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients 69
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. 68
STIMULATION OF TH 1 RESPONSE BY HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN DECREASES THE PROTECTIVE ROLE OF IgE AND EOSINOPHILS IN EXPERIMENTAL TRICHINELLOSIS 68
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. 68
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: Focus on the cancer hallmark of tumor angiogenesis 68
Z-crystallin is a new stabilizing bcl-2 mRNA au-rich element binding protein overexpressed in the acute lymphocytic leukemia Jurkat T-CELL line 66
Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis. 65
Totale 11.029
Categoria #
all - tutte 57.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.452 215 221 90 298 392 380 375 462 364 245 328 82
2020/20212.495 210 248 148 292 148 241 134 208 199 376 111 180
2021/20221.383 36 107 140 64 40 64 48 165 62 57 188 412
2022/20234.064 362 859 173 224 248 627 513 407 366 56 145 84
2023/20241.911 62 155 288 91 125 332 70 330 44 180 109 125
2024/2025133 133 0 0 0 0 0 0 0 0 0 0 0
Totale 16.344